C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
09/2006
09/21/2006	WO2005012317A3 Amylose and amylopectin derivatives
09/14/2006	US20060205931 Pharmaceutical compositions having appetite suppressant activity
09/14/2006	US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
09/12/2006	US7105493 Methods and compositions for treating flaviviruses and pestiviruses
09/05/2006	US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus
08/2006
08/22/2006	US7094763 e.g., 2-(4-Ethylbenzyl)-4-( beta -D-glucopyranosyl)-1H-indole, used for the treatment or prophylaxis of diabetes and Syndrome X.
08/16/2006	EP1689764A2 Oligonucleotides labeled with a plurality of fluorophores
08/16/2006	CN1817349A Nucleoside analogues with carboxamidine-modified monocyclic base
08/09/2006	EP1687410A1 Antisense oligonucleotides optimized for kidney targeting
08/03/2006	US20060172966 Immunostimulatory G, U-containing oligoribonucleotides
08/02/2006	EP1685147A2 Modulation of sglt2 expression
08/02/2006	CN1810822A 2-aminocarbonyl-9h-purine derivatives
08/02/2006	CN1267447C Method for segregating nucleic acid
08/02/2006	CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase
07/2006
07/27/2006	US20060166865 A modified nucleoside comprising a purine ring for treating viral infections
07/19/2006	EP1679965A2 Substituted fused heterocyclic c-glycosides
07/19/2006	EP1181298B1 Novel 8a- and 9a-15-membered lactams
07/18/2006	US7078196 Genetic engineering ; induction post-transcriptional gene blocking
07/05/2006	EP1676831A1 N,N-dialkylpolyhydroxyalkylamines
06/2006
06/29/2006	WO2005010016A3 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies
06/29/2006	WO2005000859A3 Novel reagent compounds and methods of making and using the same
06/22/2006	US20060135466 Activating a guanosine compound followed by hydrolysis; alkylating the hydrolyzed compound with subsequent amination; synthesis of 2-(2-(4-chlorophenyl) ethoxy)adenosine
06/21/2006	EP1670928A2 Single nucleotide polymorphism analysis of highly polymorphic target sequences
06/14/2006	EP1668020A2 Novel adenosine a sb 3 /sb receptor agonists
06/08/2006	WO2005118609A3 Small molecule stimulators of neuronal growth
06/08/2006	WO2005014607A3 Antisense modulation of stearoyl-coa desaturase expression
06/07/2006	EP1666092A2 Drug combination comprising a fatty acid and a uridine compound.
06/07/2006	CN1781928A Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same and method forproducing said compound
06/07/2006	CN1781927A Mevalonic acid derivative
06/07/2006	CN1781911A Intermediate for producing novel pyrazine derivatives
06/06/2006	US7056704 RNA interference mediating small RNA molecules
05/2006
05/31/2006	EP1660682A2 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
05/31/2006	CN1780847A Crystal forms of azithromycin
05/17/2006	CN1772759A N,n-dialkyl polyhydroxy alkylamines
05/11/2006	US20060100127 N,N-dialkylpolyhydroxyalkylamines
05/10/2006	CN1255422C Nucleosides
05/09/2006	US7041650 Anticonvulsant derivative salts
05/03/2006	CN1768073A Oligosaccharide derivative
04/2006
04/27/2006	WO2005118608A3 2’-nitrobenzyl-modified ribonucleotides
04/26/2006	EP1648910A2 Antisense modulation of stearoyl-coa desaturase expression
04/26/2006	EP1648909A2 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies
04/12/2006	EP1644393A2 Novel lincomycin derivatives possessing antimicrobial activity
04/12/2006	EP1465981A4 Methods and compositions for generating a genetically modified animal using lentiviral vectors
04/06/2006	WO2005123755A3 Purine nucleotide derivatives
04/05/2006	CN1756759A Methods of producing C-aryl glucoside SGLT2 inhibitors
04/05/2006	CN1249074C 2-aminocarbonyl-9H-punine derivatives
03/2006
03/29/2006	EP1124565B1 Azido derivatives of beta-l-2'-deoxy-nucleosides for the treatment of hiv infection
03/22/2006	CN1246327C Novel 8A-and 9A-15-membered lactams
03/15/2006	EP1558624B1 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/02/2006	WO2006006933A3 Antiproliferative compositions comprising aryl substituted xylopyranoside derivatives
02/2006
02/28/2006	CA2373117C 13-methyl-erythromycin derivatives
02/28/2006	CA2204204C Carbohydrate derivatives
02/22/2006	EP1627883A1 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A derivatives
02/15/2006	CN1735626A Novel anticonvulsant derivative salts
02/09/2006	WO2005111053A3 Pharmaceutical compositions having anti-inflammatory activity
02/02/2006	US20060025379 polysaccharides; packages
02/02/2006	US20060025350 4-hydroxy-2-hydroxymethyl-pyrrolidin-3-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction
01/2006
01/19/2006	WO2006006933A2 Antiproliferative compositions comprising aryl substituted xylopyranoside derivatives
01/19/2006	WO2005108411A3 Substituted pixyl protecting groups for oligonucleotide synthesis
01/17/2006	US6987175 Slurrying in aqueous solution; antibiotics
01/05/2006	WO2005016947A3 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
12/2005
12/29/2005	WO2005123755A2 Purine nucleotide derivatives
12/29/2005	WO2005042552A3 Modulation of sglt2 expression
12/29/2005	CA2568907A1 8-carbyl substituted cyclic adenosine-3'-5'-monophosphorothiolate compounds as camp modulators
12/22/2005	WO2005056570A9 Production of amino sugars
12/15/2005	WO2005118609A2 Small molecule stimulators of neuronal growth
12/15/2005	WO2005118608A2 2’-nitrobenzyl-modified ribonucleotides
12/15/2005	WO2005012318A3 Substituted fused heterocyclic c-glycosides
12/15/2005	US20050277615 Pharmaceutical compositions having anti-inflammatory activity
12/15/2005	CA2569491A1 2'-nitrobenzyl-modified ribonucleotides
12/08/2005	US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005	US20050272053 Oligonucleotides labeled with a plurality of fluorophores
12/07/2005	EP1602724A1 Magnetic pigment
12/01/2005	US20050266524 Beta integrin gene and protein
11/2005
11/24/2005	WO2005111053A2 Pharmaceutical compositions having anti-inflammatory activity
11/23/2005	EP1598054A2 Method of suppressing appetite
11/17/2005	WO2005108411A2 Substituted pixyl protecting groups for oligonucleotide synthesis
11/10/2005	WO2004099227A3 Polyol fatty acid polyesters process and polyurethanes therefrom
11/10/2005	US20050250729 Sulfonamido derivatives with a conserved ethyl uronamide group;1-deoxy-1-[6-[[[[4-[N-(benzyl)aminosulfonyl]phenyl]amino]-carbonyl]amino]-9H-purin-9-yl]-N-ethyl- beta -D-ribofuranuronamide or derivatives; anticarcinogenic, antiinflammatory, antiischemic, antiepileptic, and hypertensive agents
11/03/2005	WO2005103065A1 Anthracycline derivatives
11/02/2005	CN1690077A Compositions for the therapy and diagnosis of prostate cancer and its uses
10/2005
10/27/2005	US20050239173 Production of amino sugars
10/26/2005	EP1589023A1 Oligosaccharide derivative
10/20/2005	WO2005040180A3 Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression
10/20/2005	WO2005012320A3 Novel lincomycin derivatives possessing antimicrobial activity
10/20/2005	US20050234007 RNA interference mediating small RNA molecules
10/20/2005	US20050234006 RNA interference mediating small RNA molecules
10/19/2005	EP1585529A2 Process for the production of 2'-branched nucleosides
10/13/2005	WO2005058931A3 Methods and algorithms for identifying genomic regulatory sites
10/13/2005	US20050227920 Methods for production of recombinant vascular endothelial cell growth inhibitor
10/06/2005	US20050221316 Method for synthesising templated molecules
10/05/2005	EP1581545A1 Novel anticonvulsant derivative salts
10/05/2005	EP1581543A2 Methods of producing c-aryl glucoside sglt2 inhibitors
09/2005
09/21/2005	EP1577389A2 Magnetic pigment
09/15/2005	WO2005056569A3 Beta integrin gene and protein
09/15/2005	WO2005007663A9 Fluorogenic enzyme substrates and uses thereof
09/01/2005	US20050191653 Oligonucleotide for use in controlling expression of sodium-dependent glucose cotransporters (SGLT2) gene sequenes and treatment of diabetes
08/2005
08/18/2005	WO2005007663A3 Fluorogenic enzyme substrates and uses thereof
08/18/2005	US20050182001 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus
08/17/2005	EP1563070A2 2'-substituted oligomeric compounds and compositions for use in gene modulations

1 2 3 4 5 6 7 8 9 10 11 12